In this study we evaluated serum concentrations of IL-17 in MM patients treated with BPs. BPs caused a significant decrease of IL17 levels while ONJ subjects showed a reduction of IL-17 levels with respect to controls, although they had interrupted BPs administration from several months.
Reduced serum levels of interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration
OTERI, Giacomo;ALLEGRA, Alessandro;ALONCI, Andrea;NASTRO SINISCALCHI, Enrico;CATALFAMO, Luciano Maria;CICCIU', Domenico;DE PONTE, Francesco Saverio;MUSOLINO, Caterina
2008-01-01
Abstract
In this study we evaluated serum concentrations of IL-17 in MM patients treated with BPs. BPs caused a significant decrease of IL17 levels while ONJ subjects showed a reduction of IL-17 levels with respect to controls, although they had interrupted BPs administration from several months.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
